The World Health Organization suspended procurement and supply of Covaxin, a Covid-19 vaccine made by Bharat Biotech International Ltd., citing issues following an inspection at the company’s facilities.
The Indian vaccine maker has committed to address deficiencies in good manufacturing practices and is developing a corrective and preventive action plan, the World Health Organization said, without specifying when the suspension will be lifted. It recommended countries which have received the vaccine to “take actions as appropriate.”
The World Health Organization granted emergency use authorization to the vaccine co-developed by India’s medical research agency and the local manufacturer in November. It said the suspension does not change the vaccine’s risk assessment, and data indicates it is effective and no safety concerns exist.
Bharat Biotech on Friday said it will temporarily slow down production of Covaxin across its manufacturing facilities as it had completed supply obligations and expected a decrease in demand.
“Bharat Biotech agreed with the WHO team on the scope of the planned improvement activities and indicated that they will be executed as soon as practical,” it also said.
A spokesperson for Bharat Biotech declined to comment further on Sunday.
India’s federal health ministry spokeswoman didn’t immediately respond to requests seeking comment outside of regular business hours. More than 308 million doses of Covaxin have been administered across India, according to government data.
India’s Bharat Biotech gets official approval to test nasal COVID-19 shot as boosterIndia vaccine manufacturer Bharat Biotech on Wednesday got ‘in principle’ approval from the country’s drug regulator to test nasal COVID-19 vaccine as ... Coronavirus
India's Bharat Biotech says COVID-19 vaccine 93.4 pct effective in Phase-III trialsPhase-III trials of a vaccine made by India's Bharat Biotech showed it was 93.4 percent effective against severe symptomatic COVID-19, the firm said ... Coronavirus
Philippines approves emergency use of J&J, Bharat Biotech COVID-19 vaccinesThe Philippines’ Food and Drug Administration (FDA) has allowed the emergency use of COVID-19 vaccines made by Johnson & Johnson and India’s Bharat ... Coronavirus
Indian firm Bharat Biotech’s COVID-19 vaccine 81 pct effective, shows interim dataBharat Biotech’s vaccine showed 81 percent efficacy in preventing symptomatic COVID-19 in an interim analysis of a late-stage trial in India, it said ... Coronavirus
India’s Bharat Biotech to supply coronavirus vaccine to Brazilian distributorIndia’s Bharat Biotech has signed an agreement with a medicine distributor to supply its COVID-19 vaccine to Brazil, it said on Tuesday, even as the ... Coronavirus
Coronavirus: India’s Bharat Biotech aims to make 700 mln doses of vaccine in 2021India’s Bharat Biotech is aiming to have a production capacity of about 700 million doses of its COVID-19 vaccine this year, according to a top ... Coronavirus
COVID-19 pandemic is ‘far from over’: WHO officialA World Health Organization spokesperson said on Friday that the end of the COVID-19 pandemic was a long way off, citing a rise in cases in its latest ... Coronavirus